Harrison, M. R., Bhavsar, N. A., Wolf, S. P., Costello, B. A., Vaishampayan, U. N., Kyriakopoulos, C., … George, D. J. (2016). Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry. In Journal of Clinical Oncology (Vol. 34, pp. e16084–e16084). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.e16084

Harrison, Michael Roger, Nrupen Anjan Bhavsar, Steven Paul Wolf, Brian Addis Costello, Ulka N. Vaishampayan, Christos Kyriakopoulos, Walter Michael Stadler, et al. “Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry.” In Journal of Clinical Oncology, 34:e16084–e16084. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e16084.

Harrison MR, Bhavsar NA, Wolf SP, Costello BA, Vaishampayan UN, Kyriakopoulos C, et al. Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e16084–e16084.

Harrison, Michael Roger, et al. “Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. e16084–e16084. Crossref, doi:10.1200/jco.2016.34.15_suppl.e16084.

Harrison MR, Bhavsar NA, Wolf SP, Costello BA, Vaishampayan UN, Kyriakopoulos C, Stadler WM, Hammers HJ, Appleman LJ, Tsao C-K, Pal SK, Hussain A, Jim HSL, Borham A, George DJ. Deferred systemic therapy (DST) in the prospective metastatic renal cell cancer (MaRCC) registry. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e16084–e16084.